Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020–April 2021

OBJECTIVE: To determine the prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG nucleocapsid (N) antibodies among healthcare personnel (HCP) with no prior history of COVID-19 and to identify factors associated with seropositivity. DESIGN: Prospective cohort study. SETTING: An...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosserman, Rachel E., Farnsworth, Christopher W., O’Neil, Caroline A., Cass, Candice, Park, Daniel, Ballman, Claire, Wallace, Meghan A., Struttmann, Emily, Stewart, Henry, Arter, Olivia, Peacock, Kate, Fraser, Victoria J., Budge, Philip J., Olsen, Margaret A., Burnham, Carey-Ann D., Babcock, Hilary M., Kwon, Jennie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428156/
https://www.ncbi.nlm.nih.gov/pubmed/37592963
http://dx.doi.org/10.1017/ash.2022.375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428156/
https://www.ncbi.nlm.nih.gov/pubmed/37592963
http://dx.doi.org/10.1017/ash.2022.375

Ejemplares similares